98 related articles for article (PubMed ID: 8912539)
1. Presence of endothelial calcium-dependent nitric oxide synthase in breast apocrine metaplasia.
Tschugguel W; Knogler W; Czerwenka K; Mildner M; Weninger W; Zeillinger R; Huber JC
Br J Cancer; 1996 Nov; 74(9):1423-6. PubMed ID: 8912539
[TBL] [Abstract][Full Text] [Related]
2. Endothelial nitric oxide synthase: correlation with histologic grade, lymph node status and estrogen receptor expression in human breast cancer.
Martin JH; Begum S; Alalami O; Harrison A; Scott KW
Tumour Biol; 2000; 21(2):90-7. PubMed ID: 10686538
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide synthase activity in human breast cancer.
Thomsen LL; Miles DW; Happerfield L; Bobrow LG; Knowles RG; Moncada S
Br J Cancer; 1995 Jul; 72(1):41-4. PubMed ID: 7541238
[TBL] [Abstract][Full Text] [Related]
4. Significance of inducible nitric oxide synthase expression in benign and malignant breast epithelium: an immunohistochemical study of 151 cases.
Bulut AS; Erden E; Sak SD; Doruk H; Kursun N; Dincol D
Virchows Arch; 2005 Jul; 447(1):24-30. PubMed ID: 15947943
[TBL] [Abstract][Full Text] [Related]
5. Expression of inducible nitric oxide synthase in human breast cancer depends on tumor grade.
Tschugguel W; Schneeberger C; Unfried G; Czerwenka K; Weninger W; Mildner M; Gruber DM; Sator MO; Waldhör T; Huber JC
Breast Cancer Res Treat; 1999 Jul; 56(2):145-51. PubMed ID: 10573107
[TBL] [Abstract][Full Text] [Related]
6. Type 1 protein tyrosine kinases in benign and malignant breast lesions.
Suo Z; Emilsen E; Tveit KM; Nesland JM
Histopathology; 1998 Dec; 33(6):514-21. PubMed ID: 9870145
[TBL] [Abstract][Full Text] [Related]
7. Expression of endothelial and inducible nitric oxide synthase in benign and malignant lesions of the breast and measurement of nitric oxide using electron paramagnetic resonance spectroscopy.
Loibl S; von Minckwitz G; Weber S; Sinn HP; Schini-Kerth VB; Lobysheva I; Nepveu F; Wolf G; Strebhardt K; Kaufmann M
Cancer; 2002 Sep; 95(6):1191-8. PubMed ID: 12216084
[TBL] [Abstract][Full Text] [Related]
8. Localization of mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase type II in human breast and its disorders.
Sasano H; Frost AR; Saitoh R; Matsunaga G; Nagura H; Krozowski ZS; Silverberg SG
Anticancer Res; 1997; 17(3C):2001-7. PubMed ID: 9216657
[TBL] [Abstract][Full Text] [Related]
9. Endothelial cell nitric oxide synthase in peritumoral microvessels is a favorable prognostic indicator in premenopausal breast cancer patients.
Mortensen K; Holck S; Christensen IJ; Skouv J; Hougaard DM; Blom J; Larsson LI
Clin Cancer Res; 1999 May; 5(5):1093-7. PubMed ID: 10353743
[TBL] [Abstract][Full Text] [Related]
10. Fibroadenoma of the breast: analysis of associated pathological entities--a different risk marker in different age groups for concurrent breast cancer.
Shabtai M; Saavedra-Malinger P; Shabtai EL; Rosin D; Kuriansky J; Ravid-Megido M; Ben Haim M; Ayalon AH
Isr Med Assoc J; 2001 Nov; 3(11):813-7. PubMed ID: 11729575
[TBL] [Abstract][Full Text] [Related]
11. Co-expression and modulation of neuronal and endothelial nitric oxide synthase in human endothelial cells.
Bachetti T; Comini L; Curello S; Bastianon D; Palmieri M; Bresciani G; Callea F; Ferrari R
J Mol Cell Cardiol; 2004 Nov; 37(5):939-45. PubMed ID: 15522271
[TBL] [Abstract][Full Text] [Related]
12. Stromal nitric oxide synthase (NOS) expression correlates with the grade of mammary phyllodes tumour.
Tse GM; Wong FC; Tsang AK; Lee CS; Lui PC; Lo AW; Law BK; Scolyer RA; Karim RZ; Putti TC
J Clin Pathol; 2005 Jun; 58(6):600-4. PubMed ID: 15917410
[TBL] [Abstract][Full Text] [Related]
13. Ultrastructural localisation of nitric oxide synthase, endothelin and binding sites of lectin (from Bandeirea simplicifolia) in the rat carotid artery after balloon catheter injury.
Loesch A; Milner P; Anglin SC; Crowe R; Miah S; McEwan JR; Burnstock G
J Anat; 1997 Jan; 190 ( Pt 1)(Pt 1):93-104. PubMed ID: 9034885
[TBL] [Abstract][Full Text] [Related]
14. Expression of Tie2/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis.
Peters KG; Coogan A; Berry D; Marks J; Iglehart JD; Kontos CD; Rao P; Sankar S; Trogan E
Br J Cancer; 1998; 77(1):51-6. PubMed ID: 9459145
[TBL] [Abstract][Full Text] [Related]
15. Presence and possible significance of immunohistochemically demonstrable prolactin in breast apocrine metaplasia.
Kumar S; Mansel RE; Jasani B
Br J Cancer; 1987 Mar; 55(3):307-9. PubMed ID: 3552018
[TBL] [Abstract][Full Text] [Related]
16. Gene transfer of endothelial nitric oxide synthase improves nitric oxide-dependent endothelial function in a hypertensive rat model.
Alexander MY; Brosnan MJ; Hamilton CA; Downie P; Devlin AM; Dowell F; Martin W; Prentice HM; O'Brien T; Dominiczak AF
Cardiovasc Res; 1999 Aug; 43(3):798-807. PubMed ID: 10690352
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide synthase in human breast cancer is associated with tumor grade, proliferation rate, and expression of progesterone receptors.
Reveneau S; Arnould L; Jolimoy G; Hilpert S; Lejeune P; Saint-Giorgio V; Belichard C; Jeannin JF
Lab Invest; 1999 Oct; 79(10):1215-25. PubMed ID: 10532585
[TBL] [Abstract][Full Text] [Related]
18. [Tyrosine-protein kinase activity in breast neoplasm. Comparison with activity obtained in benign diseases and in normal tissues].
Pierart J; Oñate E; Klaassen R; Cid L; Gutierrez S; Talbot E; Ross E; Zambrano C; Burmeister R; Puchi M
Rev Med Chil; 1995 Feb; 123(2):165-75. PubMed ID: 7569456
[TBL] [Abstract][Full Text] [Related]
19. Mammary cancer antigen recognized by monoclonal antibody B72.3 in apocrine metaplasia of the human breast.
Castagna M; Nuti M; Squartini F
Cancer Res; 1987 Feb; 47(3):902-6. PubMed ID: 3542197
[TBL] [Abstract][Full Text] [Related]
20. Localization of constitutive nitric oxide synthase isoforms and the nitric oxide target enzyme soluble guanylyl cyclase in the human bladder.
Fathian-Sabet B; Bloch W; Klotz T; Niggemann S; Jacobs G; Addicks K; Engelmann U
J Urol; 2001 May; 165(5):1724-9. PubMed ID: 11342964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
